A Study is to Understand the Treatment Patterns for Immunotherapy Agents and BRAF/MEK Inhibitors Used in the Treatment of Advanced Melanoma
Clinical trial NCT03696069 · COMPLETED
Trial details
- NCT number
- NCT03696069
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-09
- Primary completion
- 2019-12-27
- Enrollment
- 501
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.